Treatment

Study population and intervention

Duration

 

Free-living healthy senior subjects (Group 1).

 

1

No intervention; Baseline (Males n = 20 + Females n = 10); Total (n) = 30                

Weeks 1-4 (Phase I)

2

Diet supplementation with NS-7; 2 capsules/d (Subgoup A)

Weeks 5-8 (Phase II)

3

No intervention; Baseline (Males n = 24 + Females n = 15); Total (n) = 39                

Weeks 1-4 (Phase I)

4

Diet supplementation with NS-6; 2 capsules/d (Subgroup B)

Weeks 5-8 (Phase II)

 

Hypercholesterolemic human subjects (Group 2)

 

5

No intervention; Baseline (Males n = 32 + Females n = 9); Total (n) = 41                

Weeks 1-4 (Phase I)

6

 Implementation of AHA Step-1 diet + NS-7, 2 capsules/d; (Subgroup C)

Weeks 5-8 (Phase II)

7

No intervention; Baseline (Males n = 20 + Females n = 10); Total (n) = 30                

Weeks 1-4 (Phase I)

8

Implementation of AHA Step-1 diet + NS-6, 2 capsules/d; (Subgoup D)

Weeks 5-8 (Phase II)

Table 2: Study design of nutritional supplemention (NS-7 and NS-6 ) with or without implementation of AHA Step-1 diet in free living healthy seniors or hypercholesterolemic human subjects.